When contacted, the company declined to share any further details about the order.

The Kolkata-headquartered firm had suspended manufacturing at all its five cigarette factories saying there was a lack of clarity in policy regarding printing of larger pictorial warnings on the packets. All other cigarette manufacturers had taken similar decisions.

A notification by the Health Ministry on September 24, 2015, for implementation of the Cigarettes and other Tobacco Products (Packaging and Labeling) Amendment Rules, 2014, had come into force on April 1, 2016.

On April 1, the Tobacco Institute of India (TII), of which ITC, Godfrey Philips and VST are part of, had stated that its members have decided to shut all their factories and stop manufacturing in the wake of larger pictorial warnings covering 85 per cent of packaging space coming into effect.

The companies, which account for more than 98 per cent of the country's domestic sales of duty-paid cigarettes in India, put the estimated production revenue loss at over Rs 350 crore per day for tobacco product manufacturers.

The all-equity merger deal includes an exchange ratio of 4.39 HUL shares for each GSK Consumer India share, along with GSK entire operations of nutrition business and contract to distribute the latter's over-the-counter (OTC) and oral care brands such as Sensodyne, Eno and Crocin.